Day: December 11, 2020

Westport, CT, Dec. 11, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the purchase of three PURE EP™ Systems by St. David’s HealthCare of Austin, Texas. St. David’s Medical Center, an HCA Healthcare owned hospital, has been recognized with a Malcolm Baldrige National quality award – the highest presidential honor for performance excellence.“Our first commercial sale to St. David’s HealthCare is an important milestone as we proceed in expanding our installed base nationwide,” said Kenneth L. Londoner, Chairman, and CEO of BioSig Technologies, Inc. “This installation cements our valued relationship...

Accenture’s Five Frontline Trends of 2020 were reviewed at the event as well as the important role Zero-Trust Solutions played this year and going forwardHERZLIYA, Israel, Dec. 11, 2020 (GLOBE NEWSWIRE) — Safe-T® Group Ltd. (NASDAQ, TASE: SFET), a provider of Secure Access solutions for on-premise and hybrid cloud environments, announced it had hosted a virtual event – webinar with Accenture, a global professional services company with leading capabilities in digital, cloud and security. Eitan Bremler, Co-Founder & VP Corporate Development of Safe-T, demonstrated Safe-T’s Zero Trust-based network access solutions (ZTNA) as part of the discussion on Accenture’s 2020 Cyber Threatscape Report1. The virtual event was featured from Spain.Safe-T’s ZTNA platform supports existing VPN solutions, removes...

Vaisala CorporationManagers’ TransactionsDecember 11, 2020 at 2.30 p.m. (EET)Vaisala Corporation: Managers’ Transactions – Kaarina MuurinenVaisala Oyj – Managers’ Transactions____________________________________________Person subject to the notification requirementName: Muurinen, KaarinaPosition: Chief Financial OfficerIssuer: Vaisala OyjLEI: 743700RNDD7KU11HW873Notification type: INITIAL NOTIFICATIONReference number: 743700RNDD7KU11HW873_20201211123501_4____________________________________________Transaction date: 2020-12-09Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009900682Nature of the transaction: DISPOSALTransaction details(1): Volume: 4,566 Unit price: 37.5 EURAggregated transactions(1): Volume: 4,566 Volume weighted average price: 37.5 EURMore informationKatriina Vainio, Group General CounselTel....

Vaisala OyjJohtohenkilöiden liiketoimet11.12.2020 klo 14:30Vaisala Oyj: Johtohenkilöiden liiketoimet – Kaarina MuurinenVaisala Oyj – Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Muurinen, KaarinaAsema: TalousjohtajaLiikkeeseenlaskija: Vaisala OyjLEI: 743700RNDD7KU11HW873Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 743700RNDD7KU11HW873_20201211123501_4____________________________________________Liiketoimen päivämäärä: 2020-12-09Kauppapaikka: NASDAQ HELSINKI LTD (XHEL)Instrumenttityyppi: OSAKEISIN: FI0009900682Liiketoimen luonne: LUOVUTUSLiiketoimien yksityiskohtaiset tiedot(1): Volyymi: 4 566 Yksikköhinta: 37,5 EURLiiketoimien yhdistetyt tiedot(1): Volyymi: 4 566 Keskihinta: 37,5 EURLisätietojaKatriina Vainio, lakiasiainjohtajaPuh. 040 079 0212Vaisala OyjJakeluNasdaq HelsinkiKeskeiset...

THE WOODLANDS, Texas, Dec. 11, 2020 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for the development of LX9211 in diabetic peripheral neuropathic pain.“The FDA’s Fast Track designation of LX9211 reflects the serious unmet medical need of people suffering from diabetic peripheral neuropathic pain,” said Praveen Tyle, Ph.D., executive vice president of research and development. “We look forward to working closely with the FDA throughout the clinical development process to bring this potential new innovative treatment to patients as quickly as possible.”Lexicon is currently enrolling patients with diabetic peripheral neuropathic pain in a Phase 2 proof-of-concept study of LX9211 and is preparing to initiate...

ROCHESTER, Mich., Dec. 11, 2020 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced its virtual communication solution, TelaRepTM , has been recognized as one of the most innovative products for life sciences by PM360 Magazine.PM360, a leading publication for marketing decision makers in the life sciences, recognizes the healthcare industry’s most innovative companies, startups, divisions, products, services, and strategies on its annual Innovation issue. The PM360 editorial staff reviewed hundreds of submissions across all categories and selected the top 16 innovative products for life sciences this year.“Innovation has been and will continue to be crucial as our industry, and the world at large continues to deal with COVID-19...

CAMBRIDGE, Mass., Dec. 11, 2020 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced that it has entered into a securities purchase agreement with a select group of institutional investors and accredited investors for a $90 million private placement, which is expected to close on or about December 15, 2020, subject to the satisfaction of customary closing conditions.The private placement includes new investors Suvretta Capital Management, LLC and Aspire Capital Fund, LLC and existing investors, including RA Capital Management, Perceptive Advisors, LLC, Bain Capital Life Sciences, EcoR1 Capital, LLC, Boxer Capital, and Ikarian Capital, LLC, as well as certain board members and executive officers.Barclays...

Contract increases number of FLEXITY Zurich trams ordered to 110FLEXITY Zurich trams won the coveted Red Dot Design Award this year, based on a successful mix of retro elements, which create a direct link to the city, a friendly interior design and state-of-the-art technologyBERLIN, Dec. 11, 2020 (GLOBE NEWSWIRE) —Note to editors: To view the photo associated with this press release, please visit the following link: https://www.globenewswire.com/NewsRoom/AttachmentNg/b5a20f20-fc7b-475c-971e-861076da49d5Global mobility leader Bombardier Transportation and Zurich Public Transport operator VBZ have signed a contract for 40 additional BOMBARDIER FLEXITY low-floor trams for Zurich. This is part of an option from the contract awarded to Bombardier by VBZ in March 2017 for 70 FLEXITY trams with an option for a further 70. Today’s option...

Le contrat porte à 110 le nombre de tramways FLEXITY commandés pour ZurichLes tramways FLEXITY pour la ville de Zurich ont remporté cette année le très convoité prix du concours « Red Dot Design » grâce à une combinaison réussie d’éléments rétro qui créent un lien direct avec la ville, un design intérieur convivial et une technologie de pointeBERLIN, 11 déc. 2020 (GLOBE NEWSWIRE) —Note aux rédacteurs : Pour voir la photo associée à ce communiqué, veuillez visiter le lien suivant : https://www.globenewswire.com/NewsRoom/AttachmentNg/b5a20f20-fc7b-475c-971e-861076da49d5/frBombardier Transport, chef de file mondial de la technologie de la mobilité, et l’exploitant du réseau de transport public de Zurich VBZ ont signé un contrat portant sur 40 tramways à plancher bas BOMBARDIER FLEXITY supplémentaires pour Zurich. Cet ajout fait partie...

Der Vertrag erhöht die Zahl der bestellten FLEXITY-Trams in Zürich auf 110Die FLEXITY Zürich Trams gewannen in diesem Jahr den begehrten Red Dot Design Award aufgrund einer gelungenen Mischung aus Retro-Elementen, die eine direkte Verbindung zur Stadt schaffen, einem freundlichen Innendesign und modernster TechnologieBERLIN, Dec. 11, 2020 (GLOBE NEWSWIRE) —Foto zu dieser Pressemitteilung finden Sie unter den folgenden Link: https://www.globenewswire.com/NewsRoom/AttachmentNg/b5a20f20-fc7b-475c-971e-861076da49d5/deDer weltweit führende Mobilitätsanbieter Bombardier Transportation und die Verkehrsbetriebe Zürich (VBZ) haben einen Vertrag über 40 zusätzliche BOMBARDIER FLEXITY Niederflur-Trams für Zürich unterzeichnet. Dies ist ein Teil einer Option aus dem Vertrag, den Bombardier von den VBZ im März 2017 für 70 FLEXITY-Trams mit einer...